Both caloric restriction and intermittent fasting extend lifespan in model organisms, but they do so through overlapping but distinct mechanisms. Here is what the evidence says for humans.
Two of the most studied dietary strategies for extending lifespan are caloric restriction (CR) and intermittent fasting (IF). Both have produced dramatic results in animal models. Both activate overlapping longevity pathways. And both have enthusiastic human proponents. But the question of which is more effective — and for whom — is considerably more nuanced than popular accounts suggest.
The importance of getting this right goes beyond academic interest. Dietary interventions are among the most universally accessible longevity tools available — they require no prescription, no expensive equipment, and are applicable regardless of age or health status. Understanding what the evidence actually shows, rather than what popular books and podcasts claim, is essential for making informed decisions about how to eat for a longer, healthier life.
Caloric restriction — consuming approximately 20-40% fewer calories than ad libitum intake while maintaining adequate nutrition — is the most robustly documented longevity intervention in laboratory organisms. The evidence is extraordinary in its breadth and consistency:
This convergence across phylogenetically distant species strongly suggests CR is targeting deeply conserved biological mechanisms rather than species-specific quirks. Few interventions in all of biology have been reproduced in so many organisms with such consistent results.
The mechanisms by which CR extends lifespan are now well-characterised at the molecular level. CR downregulates mTOR (mechanistic target of rapamycin) — the cellular growth and anabolism signalling pathway whose inhibition appears to be one of the most conserved and powerful longevity interventions known. Lower mTOR activity triggers a shift from growth and replication toward maintenance, repair, and stress resistance. CR upregulates AMPK (AMP-activated protein kinase), which improves mitochondrial function, promotes autophagy, and increases fatty acid oxidation. CR reduces circulating IGF-1, which is associated with accelerated aging at chronically high levels — probably because high IGF-1 keeps cells in growth mode when they should be in maintenance mode. And CR reliably induces autophagy — the cellular clean-up process that removes damaged proteins and organelles and is increasingly recognised as central to healthy aging.